Display options
Cite
Horton JS, Stokes AJ. The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma. Oncoimmunology. 2014;3(1):e28288doi: 10.4161/onci.28288.
Horton, J. S., & Stokes, A. J. (2014). The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma. Oncoimmunology, 3(1), e28288. https://doi.org/10.4161/onci.28288
Horton, Jaime S, and Stokes, Alexander J. "The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma." Oncoimmunology vol. 3,1 (2014): e28288. doi: https://doi.org/10.4161/onci.28288
Horton JS, Stokes AJ. The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma. Oncoimmunology. 2014 Jan 01;3(1):e28288. doi: 10.4161/onci.28288. Epub 2014 Apr 15. PMID: 24800179; PMCID: PMC4006860.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2014 Jan 01;3(1):e28288. doi: 10.4161/onci.28288. Epub 2014 Apr 15.

The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.

Oncoimmunology

Jaime S Horton, Alexander J Stokes

Affiliations

  1. Laboratory of Experimental Medicine; John A. Burns School of Medicine; Honolulu, HI USA ; Department of Cell and Molecular Biology; John A. Burns School of Medicine; Honolulu, HI USA.
  2. Laboratory of Experimental Medicine; John A. Burns School of Medicine; Honolulu, HI USA ; Department of Cell and Molecular Biology; John A. Burns School of Medicine; Honolulu, HI USA ; Chaminade University; Honolulu, HI USA.

PMID: 24800179 PMCID: PMC4006860 DOI: 10.4161/onci.28288

[No abstract available.]

Keywords: EVER1; EVER2; Epidermodysplasia verruciformis; TMC6; TMC8; cutaneous squamous cell carcinoma; papillomavirus

References

  1. Clin Dermatol. 1997 Mar-Apr;15(2):181-98 - PubMed
  2. Nat Genet. 2002 Dec;32(4):579-81 - PubMed
  3. Nucleic Acids Res. 2010 Jul;38(Web Server issue):W576-81 - PubMed
  4. Trends Genet. 1997 Oct;13(10):410-4 - PubMed
  5. J Clin Invest. 2012 Sep;122(9):3239-47 - PubMed
  6. Int J Dermatol. 2003 Apr;42(4):296-300 - PubMed
  7. Virus Res. 2009 Aug;143(2):195-208 - PubMed
  8. Nat Genet. 2002 Mar;30(3):277-84 - PubMed
  9. Virus Res. 2012 Oct;169(1):48-53 - PubMed
  10. PLoS One. 2012;7(6):e39995 - PubMed
  11. Nature. 1980 Nov 13;288(5787):159-61 - PubMed
  12. J Am Acad Dermatol. 1990 Mar;22(3):423-7 - PubMed
  13. J Virol. 2008 Dec;82(23):11486-94 - PubMed
  14. BMC Genomics. 2003 Jun 17;4(1):24 - PubMed
  15. Nat Genet. 2002 Mar;30(3):257-8 - PubMed
  16. Br J Cancer. 2011 Jan 4;104(1):24-32 - PubMed
  17. Nat Rev Immunol. 2009 Sep;9(9):630-44 - PubMed
  18. J Clin Immunol. 2013 Jan;33(1):14-21 - PubMed
  19. J Eur Acad Dermatol Venereol. 2003 Jul;17(4):394-8 - PubMed
  20. PLoS One. 2012;7(8):e44010 - PubMed
  21. J Invest Dermatol. 2008 Mar;128(3):732-5 - PubMed
  22. Br J Cancer. 2002 Jul 29;87(3):319-23 - PubMed
  23. J Gen Physiol. 2013 Nov;142(5):493-505 - PubMed
  24. Hereditas. 2001;135(1):61-3 - PubMed
  25. Front Immunol. 2011 Nov 08;2:54 - PubMed
  26. Nat Rev Immunol. 2004 Jan;4(1):46-54 - PubMed
  27. Semin Immunol. 2006 Dec;18(6):362-74 - PubMed
  28. Cell Death Dis. 2013 Feb 21;4:e499 - PubMed
  29. EMBO J. 1999 Oct 1;18(19):5359-69 - PubMed
  30. J Invest Dermatol. 2001 Oct;117(4):935-42 - PubMed
  31. Adv Exp Med Biol. 2008;624:283-95 - PubMed
  32. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7 - PubMed
  33. PLoS One. 2011;6(11):e27655 - PubMed
  34. J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):966-73 - PubMed
  35. Clin Exp Dermatol. 2005 Sep;30(5):573-4 - PubMed
  36. J Invest Dermatol. 2000 Jun;114(6):1148-53 - PubMed
  37. Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):E1473-80 - PubMed
  38. J Gen Virol. 1997 Feb;78 ( Pt 2):401-11 - PubMed
  39. J Virol. 2013 Nov;87(22):12158-65 - PubMed
  40. Virus Res. 2012 Feb;163(2):609-16 - PubMed
  41. Virology. 2010 May 25;401(1):70-9 - PubMed
  42. EMBO J. 2002 Sep 2;21(17):4741-8 - PubMed
  43. Virology. 2004 Jun 20;324(1):17-27 - PubMed
  44. Environ Health Perspect. 1996 May;104 Suppl 3:579-84 - PubMed
  45. J Invest Dermatol. 1998 Apr;110(4):311-7 - PubMed
  46. J Invest Dermatol. 2001 Jul;117(1):59-66 - PubMed
  47. J Invest Dermatol. 1998 May;110(5):752-5 - PubMed
  48. Int J Cancer. 2012 Jan 15;130(2):349-55 - PubMed
  49. Cancer Res. 2005 Feb 15;65(4):1394-400 - PubMed
  50. Cancer Res. 1979 Mar;39(3):1074-82 - PubMed
  51. J Virol. 2006 Dec;80(24):12420-4 - PubMed
  52. Genomics. 2003 Sep;82(3):300-8 - PubMed
  53. Top Antivir Med. 2012 Dec;20(5):173-9 - PubMed
  54. South Med J. 2003 Jun;96(6):613-5 - PubMed
  55. J Invest Dermatol. 1990 Jun;94(6):769-76 - PubMed
  56. Dis Markers. 2010;29(3-4):199-206 - PubMed
  57. J Dermatol Sci. 2011 May;62(2):84-90 - PubMed
  58. J Infect Dis. 2007 Sep 15;196(6):876-83 - PubMed
  59. J Invest Dermatol. 1984 Jul;83(1 Suppl):18s-25s - PubMed
  60. J Clin Microbiol. 2003 Jun;41(6):2509-14 - PubMed
  61. J Natl Compr Canc Netw. 2010 Aug;8(8):888-96 - PubMed
  62. J Invest Dermatol. 1997 May;108(5):712-5 - PubMed
  63. Arch Dermatol. 2011 May;147(5):590-6 - PubMed
  64. Toxicology. 2003 Jul 15;189(1-2):21-39 - PubMed
  65. J Invest Dermatol. 1998 Oct;111(4):696-701 - PubMed
  66. Eur J Dermatol. 2013 Apr 30;: - PubMed
  67. Arch Dermatol. 1977 Apr;113(4):495-9 - PubMed
  68. Arch Virol. 2005 Jan;150(1):145-51 - PubMed
  69. J Virol. 2004 Dec;78(24):13613-26 - PubMed
  70. PLoS Pathog. 2012;8(7):e1002807 - PubMed
  71. J Am Acad Dermatol. 2009 Feb;60(2):315-20 - PubMed
  72. PLoS One. 2012;7(7):e41743 - PubMed
  73. Australas J Dermatol. 2009 Feb;50(1):44-7 - PubMed
  74. Am J Med Sci. 1992 Sep;304(3):174-9 - PubMed
  75. Dermatologica. 1976;153(4):218-27 - PubMed
  76. J Virol. 2006 Nov;80(22):11153-64 - PubMed
  77. Nature. 2013 Feb 7;494(7435):95-99 - PubMed
  78. J Gen Virol. 1995 Aug;76 ( Pt 8):1945-58 - PubMed
  79. J Invest Dermatol. 1999 Mar;112(3):259-63 - PubMed
  80. J Dermatol. 2003 Mar;30(3):203-9 - PubMed
  81. PLoS Pathog. 2012;8(7):e1002833 - PubMed
  82. Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5259-64 - PubMed
  83. J Virol. 2005 Dec;79(23):14899-908 - PubMed
  84. Int J Mol Med. 2009 Jul;24(1):51-5 - PubMed
  85. Hum Mutat. 2006 Nov;27(11):1092-103 - PubMed
  86. J Am Acad Dermatol. 2007 Nov;57(5 Suppl):S78-80 - PubMed
  87. Cancer Surv. 1998;32:69-113 - PubMed
  88. Carcinogenesis. 2010 Dec;31(12):2155-64 - PubMed
  89. Arch Dermatol. 2002 May;138(5):649-54 - PubMed
  90. Cancer Res. 2003 Nov 1;63(21):7515-9 - PubMed
  91. Exp Dermatol. 2011 Jan;20(1):71-3 - PubMed
  92. Nat Rev Cancer. 2010 Aug;10(8):550-60 - PubMed
  93. Dermatologica. 1981;162(3):141-7 - PubMed
  94. Curr Opin Virol. 2013 Aug;3(4):416-21 - PubMed
  95. Virology. 2013 Aug 15;443(1):69-79 - PubMed
  96. Apoptosis. 2007 Mar;12(3):549-60 - PubMed
  97. Br J Cancer. 2004 Jun 1;90(11):2203-9 - PubMed
  98. J Invest Dermatol. 2005 Jul;125(1):93-7 - PubMed
  99. Vaccine. 2006 Mar 30;24 Suppl 1:S16-22 - PubMed
  100. Blood. 2012 Apr 12;119(15):3458-68 - PubMed
  101. J Exp Med. 2008 Jan 21;205(1):35-42 - PubMed
  102. J Dermatol Sci. 2011 Oct;64(1):7-15 - PubMed
  103. J Cutan Pathol. 2002 Sep;29(8):480-9 - PubMed
  104. J Dermatol. 2000 Feb;27(2):73-86 - PubMed
  105. Int J Cancer. 2002 Sep 1;101(1):61-8 - PubMed
  106. Genes Dev. 2000 Dec 1;14(23):3065-73 - PubMed
  107. J Hum Genet. 2004;49(4):223-225 - PubMed
  108. Antioxid Redox Signal. 2010 Jan;12(1):53-91 - PubMed

Publication Types

Grant support